Despite its tumor-suppressive activities, numerous studies have also revealed oncogenic roles of IRF5: Fang et al. found that IRF5 promotes glycolysis and progression of hepatocellular carcinoma [23]. This evidence concerns the gene IRF5 and hepatocellular carcinoma.